As of Jan 17
| -0.0108 / -1.53%|
The 2 analysts offering 12-month price forecasts for Biocept Inc have a median target of 2.25, with a high estimate of 3.00 and a low estimate of 1.50. The median estimate represents a +222.67% increase from the last price of 0.70.
The current consensus among 2 polled investment analysts is to Buy stock in Biocept Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.